FBN1 and colorectal carcinoma: The sensitivity of the MSP assay for CRC was significantly higher than that of FOBT in Dukes A stage (SNCA: 64.7% versus 29.4%, P = 0.039; FBN1 76.5% versus 29.4%, P = 0.006) (Table 2).